Reconstructing blood from induced pluripotent stem cells

Eirini P. Papapetrou, Michel Sadelain

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


The direct reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) offers exciting prospects for disease modelling and regenerative medicine. Several recent reports support the feasibility of generating various blood cell types from iPSCs through in vitro-directed differentiation. However, the derivation of hematopoietic stem cells (HSCs) capable of long-term reconstitution of all hematopoietic lineages appears to be more challenging. These hurdles notwithstanding, cell engineering strategies aiming to correct genetic defects at the stem cell level are already emerging. Robust methodologies for the generation of definitive human HSCs conferring high-level, multilineage, long-term, hematopoietic reconstitution thus are direly needed before the therapeutic potential and safety of iPSC-derived cell products can be thoroughly investigated.

Original languageEnglish
Article number44
JournalF1000 Medicine Reports
Issue number1
StatePublished - 16 Jun 2010
Externally publishedYes


Dive into the research topics of 'Reconstructing blood from induced pluripotent stem cells'. Together they form a unique fingerprint.

Cite this